Metraipolis › archive › dc_be403fdf010a

Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives — Europe PMC PMID:41137772

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41137772
DOI: 10.1021/acs.jmedchem.5c01596
License (as archived): solo-consultazione
Archived: 2026-11-09T01:32:25.409Z
SHA-256 of the archived text: 0563e8c305631d32295b9745b92116ef2f6d12e1bc6986bc412d765855a6da30
Stable URL of this page: https://metraipolis.com/documento/dc_be403fdf010a

How to cite

Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives — Europe PMC PMID:41137772 — Europe PMC (en), https://europepmc.org/article/MED/41137772 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be403fdf010a (Metraipolis archive dc_be403fdf010a, sha256 0563e8c305631d32295b9745b92116ef2f6d12e1bc6986bc412d765855a6da30)

BibTeX

@misc{dcbe403fdf010a,
  title = {Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives — Europe PMC PMID:41137772},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41137772},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be403fdf010a; sha256 0563e8c305631d32295b9745b92116ef2f6d12e1bc6986bc412d765855a6da30},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41137772. Agents can read the archived copy with the MCP tool read_document.